Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for National Healthcare (NHC) over the last 17 years, with Q3 2025 value amounting to $11.2 million.

  • National Healthcare's Depreciation & Amortization (CF) rose 507.58% to $11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.6 million, marking a year-over-year increase of 539.34%. This contributed to the annual value of $42.0 million for FY2024, which is 11.66% down from last year.
  • Latest data reveals that National Healthcare reported Depreciation & Amortization (CF) of $11.2 million as of Q3 2025, which was up 507.58% from $11.0 million recorded in Q2 2025.
  • Over the past 5 years, National Healthcare's Depreciation & Amortization (CF) peaked at $11.8 million during Q4 2023, and registered a low of $9.3 million during Q2 2024.
  • For the 5-year period, National Healthcare's Depreciation & Amortization (CF) averaged around $10.4 million, with its median value being $10.2 million (2021).
  • Per our database at Business Quant, National Healthcare's Depreciation & Amortization (CF) plummeted by 738.87% in 2024 and then surged by 1795.89% in 2025.
  • Over the past 5 years, National Healthcare's Depreciation & Amortization (CF) (Quarter) stood at $10.2 million in 2021, then increased by 3.22% to $10.5 million in 2022, then increased by 12.31% to $11.8 million in 2023, then decreased by 2.77% to $11.4 million in 2024, then decreased by 2.48% to $11.2 million in 2025.
  • Its last three reported values are $11.2 million in Q3 2025, $11.0 million for Q2 2025, and $11.0 million during Q1 2025.